New Inhaler For Equine Asthma To Be Released

Horses with breathing issues, including asthma, have had limited options when it comes to treatment; sometimes even management changes are not enough to keep a horse healthy and breathing easily. Boehringer Ingelheim is launching a new inhaler for horses later this year in their European markets. Called the Aservo EquiHaler, it’s the first approved inhalant therapy for horses with severe equine asthma.

Able to be used with one hand (so the other is free to control the horse), the inhaler has a dosing lever for easy handling. The nostril adapter gently fits inside the nostril of the horse and the inhaler creates a mist that can be inhaled deeply into the lungs. Though inhaled medications are common in treatment of human asthma, it is not common in equine veterinary medicine. The launch of this inhaler was a result of more than a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups.

The inhaled mist includes the medication ciclesonide, a corticosteroid that is activated directly in the lung and reduces lower airway inflammation.

Read more at HorseTalk.

The post New Inhaler For Equine Asthma To Be Released appeared first on Horse Racing News | Paulick Report.

DYFD Winter - 300x90

Comments are closed.